Dimensional Fund Advisors
ALGS icon

Dimensional Fund Advisors’s Aligos Therapeutics ALGS Stock Holding History

Dimensional Fund Advisors’s Portfolio ALGS Stock Details ALGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$121K Buy
+21,044
New +$130K ﹤0.01% 3121
2025
Q2 		– Sell
-11,216
Closed -$92.5K – 3273
2025
Q1 		$92.5K Buy
+11,216
New +$246K ﹤0.01% 3210

Other funds holding ALGS

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Dimensional Fund Advisors's ALGS Position: Q2 2026 in Review

Dimensional Fund Advisors opened a new position in Aligos Therapeutics (ALGS) in Q2 2026: 21,044 shares worth $121K. The stake represents ﹤0.01% of the portfolio and ranks #3121 among its holdings. This is a return to the name: Dimensional Fund Advisors previously reported a position in ALGS as recently as Q1 2025.

Dimensional Fund Advisors first reported a position in ALGS in Q1 2025 and has held it in 2 quarters since. 31 funds tracked by Wall St. Rank hold ALGS as of Q2 2026.

  • Dimensional Fund Advisors held 21,044 shares of Aligos Therapeutics worth $121K as of Q2 2026.
  • Aligos Therapeutics was a new Dimensional Fund Advisors position in Q2 2026.
  • Aligos Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #3121 holding.
  • Dimensional Fund Advisors first reported a position in Aligos Therapeutics in Q1 2025 and has held it in 2 quarters since.
  • 31 funds tracked by Wall St. Rank held Aligos Therapeutics as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.